跳至主要内容
临床试验/NCT02194855
NCT02194855已完成4 期

Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic Analysis.

Fudan University0 个研究点目标入组 100 人开始时间: 2015年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
主要终点
the blood flow in the right and middle hepatic veins

研究概览

简要总结

The investigators investigated whether laparoscopic versus open surgical approaches affected the pharmacokinetic and pharmacodynamic of a single bolus dose of rocuronium or cisatracurium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • American Society of Anesthesiology 1-2
  • BMI 18-30 kg.m-2
  • elective gynaecological operations under general anaesthesia

排除标准

  • cirrhosis
  • hepatitis
  • heart failure
  • arrhythmia
  • renal dysfunction
  • electrolyte disturbances
  • acid-base imbalances
  • neuromuscular disorders

研究组 & 干预措施

laparoscopic operation on rocuronium

Experimental

according different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.

干预措施: rocuronium (Drug)

laparoscopic operation on cisatracurium

Experimental

according different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.

干预措施: cisatracurium (Drug)

conventional open surgery on rocuronium

Experimental

according different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.

干预措施: rocuronium (Drug)

conventional open surgery on cisatracurium

Experimental

according different surgical type, all patients were divided into 2 groups: the laparoscopic surgery group and open surgery group.Each group were randomly assigned to the rocuronium group and cisatracurium group.

干预措施: cisatracurium (Drug)

结局指标

主要结局

the blood flow in the right and middle hepatic veins

时间窗: up to 9 months

Measurements of the blood flow in the right and middle hepatic veins were performed at baseline and 1,5, 10, 20, 30min after insufflation of carbon dioxide or incise the skin as well as 1 and 5 min after deflation or close the wound.

次要结局

  • the plasma Concentration of rocuronium and cisatracurium(up to 9 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tingting Wang

Tingting Wang

Fudan University

相似试验